[go: up one dir, main page]

AU2001291627A1 - Sustained release particle dispersion - Google Patents

Sustained release particle dispersion

Info

Publication number
AU2001291627A1
AU2001291627A1 AU2001291627A AU9162701A AU2001291627A1 AU 2001291627 A1 AU2001291627 A1 AU 2001291627A1 AU 2001291627 A AU2001291627 A AU 2001291627A AU 9162701 A AU9162701 A AU 9162701A AU 2001291627 A1 AU2001291627 A1 AU 2001291627A1
Authority
AU
Australia
Prior art keywords
compositions
sustained release
particle dispersion
release particle
preproducts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291627A
Inventor
Roland Bodmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001291627A1 publication Critical patent/AU2001291627A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paints Or Removers (AREA)
  • Silicon Polymers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fireproofing Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The invention relates to extended release compositions that can be advantageously used as drug products, plant protection agents, in foods or other products. The invention especially relates to liquid compositions in which extended release particles are dispersed. The compositions according to this invention are available in the form of single-dose or multi-dose compositions and as such are produced from liquid preproducts. The invention further relates to kits and methods for producing the compositions and to the preproducts thereof.
AU2001291627A 2000-09-05 2001-09-04 Sustained release particle dispersion Abandoned AU2001291627A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10044545A DE10044545A1 (en) 2000-09-05 2000-09-05 Retardpartikeldispersion
DE10044545 2000-09-05
PCT/DE2001/003438 WO2002019988A2 (en) 2000-09-05 2001-09-04 Sustained release particle dispersion

Publications (1)

Publication Number Publication Date
AU2001291627A1 true AU2001291627A1 (en) 2002-03-22

Family

ID=7655571

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291627A Abandoned AU2001291627A1 (en) 2000-09-05 2001-09-04 Sustained release particle dispersion

Country Status (9)

Country Link
US (1) US7820202B2 (en)
EP (1) EP1317254B1 (en)
AT (1) ATE355051T1 (en)
AU (1) AU2001291627A1 (en)
DE (3) DE10044545A1 (en)
DK (1) DK1317254T3 (en)
ES (1) ES2283433T3 (en)
PT (1) PT1317254E (en)
WO (1) WO2002019988A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055100A1 (en) * 1997-06-05 1998-12-10 Roland Bodmeier Multiphase system
US20050194060A1 (en) * 2004-03-03 2005-09-08 Vincent Houwaert Peelable seal closure assembly
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4708795B2 (en) 2002-12-20 2011-06-22 ニコノヴァム エービー Physically and chemically stable nicotine-containing particulate matter
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
EP1781264B1 (en) 2004-08-04 2013-07-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2007104573A2 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
JP2010531807A (en) 2007-05-25 2010-09-30 トルマー セラピューティクス， インコーポレイテッド Slow-broadcast formulation of risperidone compound
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US8833378B2 (en) * 2008-09-17 2014-09-16 Niconovum Ab Process for preparing snuff composition
US10137280B2 (en) 2011-06-30 2018-11-27 Incube Labs, Llc System and method for treatment of hemorrhagic stroke
US10130514B2 (en) 2011-09-26 2018-11-20 Incube Labs, Llc System and method for delivery of a therapeutic agent to the inner ear
DE102012221460A1 (en) * 2012-11-23 2014-06-12 Beiersdorf Ag Use of triethyl citrate as a denaturant for ethanol
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
JP2016512523A (en) 2013-03-11 2016-04-28 デュレクト コーポレーション Controlled release composition for injection comprising a highly viscous liquid carrier
EP4027988A4 (en) * 2019-09-13 2023-09-13 University of Utah Research Foundation Opioid independent surgical anesthetic
JP2023515918A (en) 2020-01-13 2023-04-17 デュレクト コーポレーション Sustained release drug delivery system with reduced impurities and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
CA2176716C (en) * 1993-11-19 2009-04-07 Ramstack, J. Michael Preparation of biodegradable microparticles containing a biologically active agent
US5785682A (en) * 1995-03-22 1998-07-28 Abbott Laboratories Pre-filled syringe drug delivery system
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres
US8226598B2 (en) * 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition

Also Published As

Publication number Publication date
DE10193689D2 (en) 2003-08-07
EP1317254B1 (en) 2007-02-28
WO2002019988A3 (en) 2002-06-27
DE50112128D1 (en) 2007-04-12
PT1317254E (en) 2007-06-05
DK1317254T3 (en) 2007-06-25
US7820202B2 (en) 2010-10-26
ES2283433T3 (en) 2007-11-01
ATE355051T1 (en) 2006-03-15
EP1317254A2 (en) 2003-06-11
DE10044545A1 (en) 2002-04-04
WO2002019988A2 (en) 2002-03-14
US20030152634A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
AU2001291627A1 (en) Sustained release particle dispersion
WO2007064912A3 (en) Mometasone compositions and methods of making and using the same
AU2003232211A1 (en) Aroma particle
WO2003039459A3 (en) Viral vector production methods and compositions
WO2005009389A3 (en) Anaplastic lymphoma kinase modulators and methods of use
TWI340129B (en) Dispersion powders containing fatty acid anhydrides
WO2001058412A3 (en) Extracts from residues left in the production of wine
BG104693A (en) Fast melting oral dosage form
MX336930B (en) Ganaxolone formulations and methods for the making and use thereof.
ATE395042T1 (en) DOSAGE FORMS WHICH CONTAIN MICROPARTICLES AND PROpellant GAS
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2005066097A3 (en) Alumina-yttria particles and methods of making the same
WO2008030567A3 (en) Dry powder compound formulations and uses thereof
AU2002221702A1 (en) Pharmaceutical compositions
UA81397C2 (en) Laminated packaging material, method to make it and packaging container made of that packaging material
MXPA01008705A (en) Multiple polymeric additive systems: compositions, processes, and products thereof.
UA95088C2 (en) Composition comprising at least one anticancer drug and at least one polymer and reducing chemotherapy-induced alopecia, process for the preparation thereof
WO2004091645A3 (en) Composition comprising rosmarinic acid, borneol and ginsenoside
WO2002005643A3 (en) Biocide compositions and methods and systems employing same
WO2005058006A3 (en) Methods and compositions comprising bacteriophage nanoparticles
WO2005020965A3 (en) Skeletally targeted nanoparticles
TW200640459A (en) Particulate-stabilized injectable pharmaceutical compositions of posaconazole
PL1677818T3 (en) Stable aqueous g-csf-containing compositions
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2006129095A3 (en) Sustained release preparations of pro-insulin c-peptide